Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Olfactory Function in Parkinson's Disease
NCT01007630Phase 4Unknown
- Sponsor
- Parkinson's Institute and Clinical Center
- Start
- Nov 2009
- Primary completion
- Jan 2014
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Parkinson's Institute and Clinical Center. Status: unknown.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01007630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007630.